Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-042013
Filing Date
2020-07-09
Accepted
2020-07-09 18:00:13
Documents
2
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7813
2 POA DOCUMENT poa.txt EX-24.3_928442 2961
  Complete submission text file 0001209191-20-042013.txt   12180
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POSEIDA THERAPEUTICS, INC. 4242 CAMPUS POINT COURT, SUITE 700 SAN DIEGO CA 92121
Business Address
Mylet Johanna (Reporting) CIK: 0001765988 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39376 | Film No.: 201021273